Veracyte Inc (VCYT) - Cumulative Company Assets

Corporate emblem and logo of Veracyte Inc (VCYT)

Investments in robotic sequencers and AI diagnostics are creating a debt load that is evident in the consolidated assets through resource dynamics. The 1415.08 metric confirms the current balance sheet level. Veracyte, Inc. (VCYT) bases its cost optimization on cloud data storage and logistics outsourcing, while stability is ensured by a focus on the North American market, which eliminates geopolitical risks.

VCYT: Veracyte Inc Aggregate Company Assets 07/04/2022 - 10/28/2026

Analytical breakdowns for Veracyte Corp (VCYT)

- price and consensus price forecast:
Price veracyte.com|VCYT - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Veracyte Diagnostics|VCYT - Enterprise Value
- book capitalization data:
Book Value per Share Veracyte|VCYT - Company Book Value|Capitalization to Book Value Ratio veracyte.com|VCYT - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Veracyte, Inc.|VCYT - Long-Term Debt to Capital|Current Liabilities to Capital Veracyte Diagnostics|VCYT - Company Debts|Debt to Net Assets Ratio Veracyte Diagnostics|VCYT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Veracyte
Analysis of all company metrics:VCYT, veracyte.com
Manufactured product of Veracyte

A conservative investor assesses the fundamental stability of Veracyte, Inc. (VCYT) through the dynamics of its resource base to determine capital efficiency. An analysis of the company's total assets, calculated reverse-engineered via ROA, allows for the tracking of the scaling of intellectual property and proprietary diagnostic algorithms, which confirms the strengthening of market barriers and enhances the business's investment attractiveness within the genomic analysis sector.

Competitors of Veracyte, Inc. (VCYT)

carislifesciences.com (CAI) - Aggregate Business Assets|Company Total Assets GH|Cumulative Company Assets Celcuity Inc|Company Total Assets GRAL|Company Total Assets MYGN (Myriad)|CSTL - Aggregate Company Assets|Total Business Assets brbiotech.com BNR|VNRX: Company Total Assets|BDSX - Cumulative Company Assets|Company Total Assets PRPO|CHEK (Check-Cap) - Company Assets|MYNZ - Aggregate Company Assets|Aggregate Asset Value oncocyte.com (OCX)